Antoine Papiernik, Chairman of Sofinnova Partners, Provides Insights on Medtech 2023 Venture Capital Outlook

Welcome to the number one show in the source of Truth for all things Medtech! Here we reveal the secrets and stories behind the investments, science, and commercialization of the Medtech industry. Every week, we’ll take you on a wild ride with the biggest names in the game, from entrepreneurs and investors who are shaking up the market, to healthcare providers who are revolutionizing the way we think and practice medicine. So hold on tight and get ready for a journey like no other – this is The State of MedTech.

Everybody, welcome back to the show! I’m very happy and excited to have one of our first repeat guests back on, and that’s Antoine Papiernik, the Chairman and Managing Partner at Sofinnova Partners. Sofinnova is Europe’s largest and oldest venture capital firm, with a rich history in the industry. In this episode, Antoine shares his insights on the Medtech landscape in 2022 and his outlook for 2023, as well as some exciting announcements from Sofinnova.

As a VC, Antoine believes that life science investing is not just about recognizing good science, but also about understanding people. He values the importance of interacting with co-investors, partners, and entrepreneurs, listening, discerning, and finding common interests. Antoine’s track record and results speak for themselves, and he has been recognized as one of the world’s top venture capital investors on the Forbes Midas List.

In this episode, we cover a review of 2022 and Antoine’s predictions for 2023, as well as some interesting insights and announcements from Sofinnova Partners. Antoine is known for his vision and his commitment to his word, making him a true gentleman’s VC. He sets a great example for other investors in the industry, and we are fortunate to have him as a guest on the show.

Make sure to subscribe to our YouTube channel and LinkedIn newsletter to stay updated on the latest episodes of The State of MedTech. You can also follow us on Facebook, Twitter, and Instagram for additional content and updates. Don’t forget to connect with Antoine Papiernik and Omar M. Khateeb on LinkedIn, as well as their respective social media accounts.

Keywords/tags associated with the video: medtech, venture capital, Sofinnova Partners, venture

Original video source: [source](

Transcript source: [source](

Are you a clinician? Take 30 seconds to reflect an unlock your free AMA PRA Category 1 CME credit here

Register for LSI USA 2023 Emerging MedTech Summit now:

Get a demo of the most powerful medtech market insights platform. Head to

Connect with Antoine Papiernik

Learn more about Sofinnova Partners

Antoine Papiernik serves as the Chairman and Managing Partner at Sofinnova Partners, where he has been an initial investor and active board member in a number of public companies, including Actelion, ProQR, Shockwave Medical, NovusPharma (sold to CTI), Movetis (sold to Shire), and Pixium Vision.

He has also invested in and is a board member of private companies including Reflexion Medical, Tissium, Pi-Cardia, SafeHeal, and more.
Antoine has an MBA from the Wharton School of Business, University of Pennsylvania, and has twice been named as one of the world’s top venture capital investors on the Forbes Midas List.

Subscribe to our Youtube Channel

Subscribe to our LinkedIn Newsletter

Follow The State of MedTech on

Follow Omar M. Khateeb on

#venturecapital #venturecapitalpodcast #medicaldevices #medtech #healthtech

Leave a Reply

Your email address will not be published. Required fields are marked *

GIPHY App Key not set. Please check settings

[PODCAST] A Baby’s Brain Surgery Inside the Womb

The US Financial System’s Prosperity at Stake: The Menace of Quantum Computers